Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
90%
Epidermal Growth Factor Receptor
62%
Pharmacology
56%
Non Small Cell Lung Cancer
55%
Estrogen Receptor Positive Breast Cancer
44%
Malignant Neoplasm
43%
Survival
36%
Neoplasm
30%
Fulvestrant
29%
Everolimus
29%
Aromatase Inhibitor
29%
microRNA
29%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
29%
Statin (Protein)
29%
Epidermal Growth Factor Receptor Kinase Inhibitor
29%
Protein
23%
Erlotinib
19%
Disease
19%
Drug
17%
Apoptosis
17%
Cohort Study
17%
Breast Cancer
16%
Mitogen Activated Protein Kinase 3
16%
Progression Free Survival
16%
Mitogen Activated Protein Kinase Kinase Inhibitor
16%
Messenger RNA
16%
Biological Marker
15%
Lung Adenocarcinoma
15%
Paclitaxel
14%
STAT3 Protein
14%
Hyaluronic Acid
14%
Immune Checkpoint Inhibitor
14%
Lung Tumor
14%
Pollutant
14%
Dietary Exposure
14%
RNA-Sequencing
14%
Solid Malignant Neoplasm
14%
Metastatic Colorectal Cancer
14%
Clinical Research
14%
Naloxone
14%
B Raf Kinase
14%
Death Receptor 5
14%
Dietary Fat
14%
Phosphatidylinositol 3 Kinase
14%
Mucin 1
14%
Endocrine Therapy
14%
Actin
14%
Sorafenib
14%
2,5-Dimethoxy-4-iodoamphetamine
14%
Cetuximab
14%
Medicine and Dentistry
Patient
96%
Gene
65%
Gene Expression
54%
Lung Cancer
53%
Epidermal Growth Factor Receptor
44%
Estrogen Receptor Positive Breast Cancer
44%
Therapeutic Procedure
40%
Neoplasm
34%
Non Small Cell Lung Cancer
34%
Fulvestrant
29%
Everolimus
29%
Aromatase Inhibitor
29%
Cancer Cell
23%
Lung Adenocarcinoma
23%
Lung Cancer Cell Line
20%
Drug
20%
Signal Transduction
20%
Targeted Therapy
19%
Immunity
17%
Programmed Cell Death
17%
Examination
17%
Mutant
17%
Immune Checkpoint Inhibitor
16%
MEK Inhibitor
16%
Mitogen Activated Protein Kinase 3
16%
Progression Free Survival
16%
Cells
16%
Messenger RNA
16%
Mucin 1
14%
microRNA
14%
Sorafenib
14%
Hormone Therapy
14%
Krukenberg Tumor
14%
STAT3 Protein
14%
Fat Intake
14%
Persistent Organic Pollutant
14%
Dietary Exposure
14%
Metastatic Colorectal Cancer
14%
Cell Invasion
14%
Gene Expression Profiling
14%
Cell Survival
14%
Prevalence
14%
Autoimmune Disease
14%
Breast Cancer
14%
Kidney Cancer
14%
Experience
14%
Casein Kinase
14%
Lipid Metabolism
14%
Cetuximab
14%
Programmed Death-Ligand 1
14%
Biochemistry, Genetics and Molecular Biology
Gene Expression
100%
Gene
94%
Cancer Cell
81%
Epidermal Growth Factor Receptor
73%
Gene Expression Profiling
45%
Erlotinib
43%
MicroRNA
29%
Raf Kinase
29%
Genomics
29%
Apoptosis
27%
Immune Checkpoints
26%
KRAS
19%
Wild Type
17%
Mesenchymal-Epithelial Transition
15%
Progression Free Survival
15%
Sample
15%
Protein
15%
Cell Proliferation
15%
Isoform
14%
Lipid Metabolism
14%
Mevalonate Pathway
14%
Enzyme
14%
MUC1
14%
Toll-Like Receptor
14%
Dietary Fat
14%
STAT3
14%
Receptor Tyrosine Kinase Inhibitors
14%
Cell Survival
14%
Cellular Immunity
14%
Cell Invasion
14%
E2F
14%
Prevalence
14%
E2F1
14%
PTPN11
14%
Cancer Survival
14%
PD-L1
14%
Retinoblastoma
14%
Cetuximab
14%
2,5-Dimethoxy-4-iodoamphetamine
14%
Estrogen Receptor
14%
Phosphoinositide 3-Kinase
14%
Actin
14%
Sorafenib
14%
Time
12%
Microarrays
12%
Comprehension
11%
Cell Cycle
10%
Growth Factor Receptor Inhibitor
10%
Regulatory Mechanism
10%
Antibodies
10%